ICU Medical Announces Third Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Revolution Medicines prices RASONQUE at $39,800 per month
ICU Medical (ICUI) Q3 Revenue Tops Views, Maintains EPS Guidance
November 7, 2022 4:15 PM ESTICU Medical (NASDAQ: ICUI) reported Q3 EPS of $1.75, $0.35 worse than the analyst estimate of $2.10. Revenue for the quarter came in at $597.9 million versus the consensus estimate of $570.7 million.
GUIDANCE:
ICU Medical sees FY2022 EPS of $6.20-$6.80, versus the consensus... More
